Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Alibaba Health Information Technology Limited

Healthcare US ALBBY

9.75USD
0.27(2.85%)

Last update at 2026-06-03T13:30:00Z

Day Range

9.759.75
LowHigh

52 Week Range

8.9519.45
LowHigh

Fundamentals

  • Previous Close 9.48
  • Market Cap9715.12M
  • Volume500
  • P/E Ratio34.43
  • Dividend Yield-%
  • EBITDA1833.03M
  • Revenue TTM33021.66M
  • Revenue Per Share TTM41.02
  • Gross Profit TTM 8082.30M
  • Diluted EPS TTM0.35

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Income before tax 1559.97M 939.40M 550.99M -252.51400M 401.22M
Minority interest 0.41M 0.34M -0.85600M 0.39M -20.34600M
Net income 1432.43M 883.48M 533.41M -265.55500M 348.59M
Selling general administrative 390.59M 359.98M 379.49M 395.08M 293.60M
Selling and marketing expenses 2258.37M 1776.56M 1768.67M 1981.28M 1222.01M
Gross profit 7432.09M 5895.32M 5701.33M 4107.99M 3617.25M
Reconciled depreciation 57.60M 53.68M 63.72M 60.58M 39.63M
Ebit 1562.58M 945.37M 493.11M -792.29500M 266.18M
Ebitda 1620.18M 999.05M 556.83M -731.71900M 305.81M
Depreciation and amortization 57.60M 53.68M 63.72M 60.58M 39.63M
Non operating income net other - - - - -
Operating income 1576.06M 640.18M 493.11M -792.29500M 266.18M
Other operating expenses 29022.23M 26314.29M 26794.80M 21596.46M 15407.64M
Interest expense 2.61M 5.97M 5.83M 3.81M 2.45M
Tax provision 127.95M 56.26M 16.73M 13.43M 58.54M
Interest income 464.85M 478.03M 331.59M 209.84M 165.41M
Net interest income 462.24M 472.06M -5.83300M 206.02M 162.97M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 127.95M 56.26M 16.73M 13.43M 58.54M
Total revenue 30598.29M 27026.56M 26763.02M 20577.62M 15518.47M
Total operating expenses 5856.03M 5183.06M 5733.12M 5126.84M 3506.42M
Cost of revenue 23166.20M 21131.23M 21061.68M 16469.62M 11901.22M
Total other income expense net -16.09500M 299.22M 57.89M 539.78M 135.04M
Discontinued operations - - - - -
Net income from continuing ops 1432.01M 883.14M 534.26M -265.94100M 342.68M
Net income applicable to common shares - - - -265.55500M 348.59M
Preferred stock and other adjustments - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 21178.42M 19705.34M 20747.56M 19201.97M 17739.20M
Intangible assets 275.22M 292.07M 309.01M 326.21M 2.94M
Earning assets - - - - -
Other current assets 687.73M 1774.25M - 63.12M 11.02M
Total liab 4865.26M 5187.73M 5600.22M 5129.74M 3457.60M
Total stockholder equity 16312.18M 14544.21M 15173.71M 14098.42M 14301.95M
Deferred long term liab - - - - -
Other current liab 1743.00M 1551.83M 1685.96M 1242.88M 828.99M
Common stock 142.79M 142.78M 119.13M 119.10M 118.86M
Capital stock 142.79M 142.78M 119.13M 119.10M 118.86M
Retained earnings 1324.46M -11.97100M -841.69100M -1309.01300M -985.65200M
Other liab - - - 222.85M 39.32M
Good will 810.85M 810.85M 810.85M 810.85M 54.58M
Other assets - - - 37.68M 17.53M
Cash 2218.30M 9553.11M 10917.17M 10547.85M 11636.77M
Cash and equivalents - - - - -
Total current liabilities 4742.17M 5025.46M 5437.44M 4822.13M 3400.87M
Current deferred revenue - - - - -
Net debt -2182.78100M -9470.94000M -10839.37300M -10412.43700M -11599.02900M
Short term debt 10.58M 34.19M 37.44M 50.66M 20.33M
Short long term debt - - - - -
Short long term debt total 35.52M 82.17M 77.80M 135.41M 37.74M
Other stockholder equity 51463.79M 14413.40M 15896.26M 13979.32M 14183.09M
Property plant equipment - - - 165.11M 52.29M
Total current assets 12276.18M 13512.24M 14913.79M 13565.51M 14199.73M
Long term investments - - - - -
Net tangible assets - - - 12961.35M 14244.44M
Short term investments 5881.55M -694.00000M - - -
Net receivables 2073.39M 785.14M 578.08M 1073.94M 772.91M
Long term debt - - - - -
Inventory 1415.22M 1399.74M 2102.31M 1550.15M 1468.61M
Accounts payable 2852.38M 3350.57M 3714.05M 3528.60M 2551.55M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -36618.86600M -36859.37500M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 93.48M 86.44M 4611.52M 4316.89M 3429.68M
Deferred long term asset charges - - - - -
Non current assets total 8902.24M 6193.10M 5833.77M 5636.46M 3539.48M
Capital lease obligations 35.52M 82.17M 77.80M 135.41M 37.74M
Long term debt total - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Investments -2596.48200M -4880.90000M -532.43600M 2799.35M -4724.61400M
Change to liabilities - - 0.00000M 1029.67M 735.04M
Total cashflows from investing activities -2596.48200M -4880.90000M - 1872.31M -4961.48400M
Net borrowings - - - -47.01200M -31.61600M
Total cash from financing activities -72.51700M -1982.39500M -111.27800M -58.62800M 8922.41M
Change to operating activities - - - -44.39200M -122.06500M
Net income 1559.97M 939.40M 550.99M -252.51400M 401.22M
Change in cash -1271.87300M -5746.68100M -104.57700M 2089.15M 4657.29M
Begin period cash flow 3490.17M 9236.85M 9341.43M 7252.27M 2594.98M
End period cash flow 2218.30M 3490.17M 9236.85M 9341.43M 7252.27M
Total cash from operating activities 1395.03M 1079.83M 255.69M 424.36M 1009.43M
Issuance of capital stock 4.59M 0.88M 12.89M 9.69M 8993.71M
Depreciation 57.60M 53.68M 63.72M 60.58M 39.63M
Other cashflows from investing activities -9084.20600M 229.28M - -112.08600M -234.52800M
Dividends paid - - - - -
Change to inventory -107.88000M 614.10M -711.69400M -129.20000M -283.82600M
Change to account receivables -273.59400M -211.49200M -64.62600M -201.98300M 7.44M
Sale purchase of stock -39.93100M -104.56800M -81.58200M -16.51900M -39.58000M
Other cashflows from financing activities 0.92M -1838.77100M -42.58600M -51.80200M -31.72600M
Change to netincome - - - -24.75600M 284.62M
Capital expenditures 18.90M 22.78M 5.92M 15.12M 17.56M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -567.97100M -337.51500M -568.13000M 671.12M 294.65M
Stock based compensation 224.53M 266.06M 308.89M 408.10M 396.96M
Other non cash items 120.90M 158.21M -99.78300M -462.92200M -123.02500M
Free cash flow 1376.13M 1057.05M 249.77M 409.25M 991.87M

Peer Comparison

Sector: Healthcare Industry: Pharmaceutical Retailers

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ALBBY
Alibaba Health Information Technology Limited		 0.27 2.85% 9.75 34.43 19.84 0.29 3.79 1.73 25.72
ALBHF
Alibaba Health Information Technology Limited		 - -% 0.48 36.00 19.01 0.36 3.63 1.73 25.72
RADLY
Raia Drogasil SA ADR		 -0.18 4.90% 3.49 47.15 32.68 0.34 9.83 0.35 3.29
SHPPF
Shop Apotheke Europe N.V		 - -% 45.18 - - 2.80 2.28 1.70 78.78
CLCGY
Clicks Group Ltd		 -0.5 1.71% 28.80 22.47 31.85 0.09 10.04 1.47 10.53

Reports Covered

Stock Research & News

View All

Profile

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and family planning products, and various other health-related products. It also provides medical and healthcare services, including medical checkups, medical consultation, appointment-booking, vaccination, dental and mental care, optometry, and nursing services, as well as traditional chinese medicines. The company provides products and services to business-to-customer and business-to-business customers through offline pharmacy outlets, as well as online stores, such as Tmall, Taobao, Alipay, Ele.me, AMap, DingTalk, Freshippo, and Quark. In addition, it engages in the digital tracking business; asset management; network hospital, software technical services, healthcare related internet information and technical services and research; operation of internet hospitals, as well as Alibaba Health, flagship platform of Alibaba Group for integrated online and offline medical and healthcare resources, providing one-stop healthcare solutions. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong.

Alibaba Health Information Technology Limited

Tower One, Causeway Bay, Hong Kong

Key Executives

Name Title Year Born
Mr. Shunyan Zhu Chairman & CEO 1971
Mr. Yanwu Tu CFO & Exec. Director 1979
Mr. Difan Shen COO & Exec. Director 1979
Mr. Chun Chung Kwong Financial Controller NA
Ms. Chun Ka Yan Company Sec. NA
Ka Yan Chun Company Sec. NA
Ms. Zhang Hua Chief People Officer NA
Mr. Difan Shen CEO & Executive Director 1978
Mr. Yanwu Tu CFO & Executive Director 1979
Ms. Hiu Leong Tsui Legal Counsel & Joint Company Secretary NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.